A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements

PHASE1CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

June 25, 2024

Study Completion Date

July 9, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-279

TAK-279 capsule.

DRUG

TAK-279 Placebo

TAK-279 matching placebo capsule.

DRUG

Moxifloxacin

Moxifloxacin over-encapsulated tablet.

DRUG

Moxifloxacin Placebo

Moxifloxacin matching placebo capsule.

Trial Locations (1)

Celerion, Tempe